Revolution Medicines officer Anthony Mancini reports $162,200 share disposal

RVMD•2026-11-12

Chief Global Commercialization Officer Anthony Mancini sold 811 Revolution Medicines shares at $200 each on Nov. 9, 2026. He exercised options for 811 shares and held 39,765 shares directly after the transactions.

1. Share transactions

Anthony Mancini sold 811 common shares at $200 each on Nov. 9, 2026. He exercised options for 810 shares at $33.62 each and one share at $102.02. His direct beneficial ownership totaled 39,765 common shares after the transactions.

Sources

Revolution Medicines officer Anthony Mancini reports $162,200 share disposal

Sec

Revolution Medicines officer Anthony Mancini reports $162,200 share disposal

1. Share transactions

Related News

Kodiak Gas Services COO William Chad Lenamon reports $44,200 share sale

Lianhe Sowell International Group may offer up to $200 million in securities

Bloomin' Brands EVP Patrick M. Hafner reports sale of $202,600 in common shares

Sources

Revolution Medicines officer Anthony Mancini reports $162,200 share disposal

AppFolio principal accounting officer Don Rigler reports disposal of $58,607.82 in common shares

Globalstar VP and CFO Rebecca Clary reports sale of common shares worth $2 million